WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors : type 1 T-lymphocyte responses are associated with clinical outcome
Bron
Journal of hematology and oncology - ISSN 1756-8722-18:1 (2025) p. 1-6
Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study
Bron
PLoS ONE - ISSN 1932-6203-19:7 (2024) p. 1-15
Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma : protocol of a monocentric phase I/II clinical trial in Belgium
Bron
BMJ open - ISSN 2044-6055-14:3 (2024) p. 1-10
Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS) : a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration
Bron
BMJ open - ISSN 2044-6055-9:9 (2019) p. 1-11
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
Bron
Blood - ISSN 0006-4971-130:15 (2017) p. 1713-1721